Loading...
p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775
The Wee1 inhibitor MK1775 (AZD1775) is currently being tested in clinical trials for cancer treatment. Here, we show that the p53 target and CDK inhibitor p21 protects against MK1775-induced DNA damage during S-phase. Cancer and normal cells deficient for p21 (HCT116 p21(-/-), RPE p21(-/-), and U2OS...
Na minha lista:
| Udgivet i: | Cell Cycle |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527284/ https://ncbi.nlm.nih.gov/pubmed/30943845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2019.1593649 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|